These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 21741079)
1. Laparoscopic-assisted cytoreduction for primary advanced ovarian cancer: success, morbidity and survival. Fanning J; Yacoub E; Hojat R Gynecol Oncol; 2011 Oct; 123(1):47-9. PubMed ID: 21741079 [TBL] [Abstract][Full Text] [Related]
2. Laparoscopic cytoreduction for primary advanced ovarian cancer. Fanning J; Hojat R; Johnson J; Fenton B JSLS; 2010; 14(1):80-2. PubMed ID: 20529532 [TBL] [Abstract][Full Text] [Related]
3. Feasibility of laparoscopic debulking with electrosurgical loop excision procedure and argon beam coagulator at recurrence in patients with previous laparotomy debulking. Trinh H; Ott C; Fanning J Am J Obstet Gynecol; 2004 May; 190(5):1394-7. PubMed ID: 15167847 [TBL] [Abstract][Full Text] [Related]
4. Complete surgical cytoreduction of advanced ovarian carcinoma using the argon beam coagulator. Bristow RE; Montz FJ Gynecol Oncol; 2001 Oct; 83(1):39-48. PubMed ID: 11585412 [TBL] [Abstract][Full Text] [Related]
5. Laparoscopic treatment of early ovarian cancer: surgical and survival outcomes. Tozzi R; Köhler C; Ferrara A; Schneider A Gynecol Oncol; 2004 Apr; 93(1):199-203. PubMed ID: 15047236 [TBL] [Abstract][Full Text] [Related]
6. The addition of extensive upper abdominal surgery to achieve optimal cytoreduction improves survival in patients with stages IIIC-IV epithelial ovarian cancer. Eisenhauer EL; Abu-Rustum NR; Sonoda Y; Levine DA; Poynor EA; Aghajanian C; Jarnagin WR; DeMatteo RP; D'Angelica MI; Barakat RR; Chi DS Gynecol Oncol; 2006 Dec; 103(3):1083-90. PubMed ID: 16890277 [TBL] [Abstract][Full Text] [Related]
7. The utility of hand-assisted laparoscopy in ovarian cancer. Krivak TC; Elkas JC; Rose GS; Sundborg M; Winter WE; Carlson J; MacKoul PJ Gynecol Oncol; 2005 Jan; 96(1):72-6. PubMed ID: 15589583 [TBL] [Abstract][Full Text] [Related]
8. Survival impact of surgical cytoreduction in stage IV epithelial ovarian cancer. Bristow RE; Montz FJ; Lagasse LD; Leuchter RS; Karlan BY Gynecol Oncol; 1999 Mar; 72(3):278-87. PubMed ID: 10053096 [TBL] [Abstract][Full Text] [Related]
9. The incidence of major complications after the performance of extensive upper abdominal surgical procedures during primary cytoreduction of advanced ovarian, tubal, and peritoneal carcinomas. Chi DS; Zivanovic O; Levinson KL; Kolev V; Huh J; Dottino J; Gardner GJ; Leitao MM; Levine DA; Sonoda Y; Abu-Rustum NR; Brown CL; Barakat RR Gynecol Oncol; 2010 Oct; 119(1):38-42. PubMed ID: 20609464 [TBL] [Abstract][Full Text] [Related]
10. Feasibility and efficacy of laparoscopic management of ovarian cancer. Jung US; Lee JH; Kyung MS; Choi JS J Obstet Gynaecol Res; 2009 Feb; 35(1):113-8. PubMed ID: 19215557 [TBL] [Abstract][Full Text] [Related]
11. Surgical cytoreduction during second-look laparotomy in patients with advanced ovarian cancer. Gadducci A; Iacconi P; Fanucchi A; Cosio S; Teti G; Genazzani AR Anticancer Res; 2000; 20(3B):1959-64. PubMed ID: 10928134 [TBL] [Abstract][Full Text] [Related]
12. Laparoendoscopic single-site surgery (LESS) in gynecologic oncology: technique and initial report. Fader AN; Escobar PF Gynecol Oncol; 2009 Aug; 114(2):157-61. PubMed ID: 19481243 [TBL] [Abstract][Full Text] [Related]
13. Complete cytoreductive surgery is feasible and maximizes survival in patients with advanced epithelial ovarian cancer: a prospective study. Eisenkop SM; Friedman RL; Wang HJ Gynecol Oncol; 1998 May; 69(2):103-8. PubMed ID: 9600815 [TBL] [Abstract][Full Text] [Related]
14. Impact of secondary cytoreductive surgery on survival of patients with advanced epithelial ovarian cancer. Zang RY; Zhang ZY; Li ZT; Cai SM; Tang MQ; Chen J; Liu Q Eur J Surg Oncol; 2000 Dec; 26(8):798-804. PubMed ID: 11087649 [TBL] [Abstract][Full Text] [Related]
15. Transverse colectomy in ovarian cancer surgical cytoreduction: operative technique and clinical outcome. Bristow RE; Peiretti M; Zanagnolo V; Salani R; Giuntoli RL; Maggioni A Gynecol Oncol; 2008 Jun; 109(3):364-9. PubMed ID: 18396322 [TBL] [Abstract][Full Text] [Related]
16. Neoadjuvant chemotherapy lessens surgical morbidity in advanced ovarian cancer and leads to improved survival in stage IV disease. Hou JY; Kelly MG; Yu H; McAlpine JN; Azodi M; Rutherford TJ; Schwartz PE Gynecol Oncol; 2007 Apr; 105(1):211-7. PubMed ID: 17239941 [TBL] [Abstract][Full Text] [Related]
17. The results of treatment of epithelial ovarian cancer after centralisation of primary surgery. Results from North Jutland, Denmark. Soegaard Andersen E; Knudsen A; Svarrer T; Lund B; Nielsen K; Grove A; Tetsche M Gynecol Oncol; 2005 Dec; 99(3):552-6. PubMed ID: 16150480 [TBL] [Abstract][Full Text] [Related]
18. Neoadjuvant chemotherapy for unresectable ovarian carcinoma: a French multicenter study. Ansquer Y; Leblanc E; Clough K; Morice P; Dauplat J; Mathevet P; Lhommé C; Scherer C; Tigaud JD; Benchaib M; Fourme E; Castaigne D; Querleu D; Dargent D Cancer; 2001 Jun; 91(12):2329-34. PubMed ID: 11413522 [TBL] [Abstract][Full Text] [Related]